Ampyra and Ligament sprain - a phase IV clinical study of FDA data
Summary:
Ligament sprain is reported as a side effect among people who take Ampyra (dalfampridine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tecfidera, and have Gait disturbance.
The phase IV clinical study analyzes which people have Ligament sprain when taking Ampyra. It is created by eHealthMe based on reports of 76,998 people who have side effects when taking Ampyra from the FDA, and is updated regularly.
What is Ampyra?
Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.
What is Ligament sprain?
Ligament sprain (ligament stretched) is found to be associated with 958 drugs and 813 conditions by eHealthMe. Check the latest studies of Ligament sprain.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
76,998 people reported to have side effects when taking Ampyra.
Among them, 134 people (0.17%) have Ligament sprain.
Among these 134 people:
How long have people been on Ampyra when they have Ligament sprain? *
What is the gender of people who have Ligament sprain when taking Ampyra? *
What is the age of people who have Ligament sprain when taking Ampyra? *
What are other drugs people take besides Ampyra? *
What are other side effects people have besides Ligament sprain? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ampyra and have Ligament sprain?
- Check whether Ligament sprain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ampyra:
- Ampyra (77,145 reports)
Ligament sprain treatments and more:
- Ligament sprain (13,522 reports)
How severe was Ligament sprain and when was it recovered:
Expand to all the drugs that have ingredients of dalfampridine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ampyra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Ligament sprain:
- Ligament sprain (958 drugs)
Browse all the conditions that are associated with Ligament sprain:
- Ligament sprain (813 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dalfampridine (the active ingredients of Ampyra) and Ampyra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxybutynin Chloride and Gastric Disorder for Women aged 50-59 - 2 seconds ago
- Drug interactions of Azathioprine Sodium and Imuran - 3 seconds ago
- Could Vitamin C cause Pain In Jaw? - 3 seconds ago
- Gliclazide and Asthenia for Women aged 40-49 - 3 seconds ago
- Gliclazide and Muscle Fatigue for Women aged 40-49 - 4 seconds ago
- Gliclazide and Muscular Weakness for Women aged 40-49 - 4 seconds ago
- Gliclazide and Lack Of Strength, Muscle Weakness, Weakness for Women aged 40-49 - 4 seconds ago
- Gliclazide and Muscle Weakness for Women aged 40-49 - 5 seconds ago
- Gliclazide and Lack Of Strength for Women aged 40-49 - 5 seconds ago
- Drug interactions of Magnesium and Gemtesa - 5 seconds ago